Print

Noven Pharmaceuticals Inc. (NOVN) Completes Acquisition of Daytrana(R) Methylphenidate Transdermal System (CII) from Shire plc  
10/1/2010 11:12:47 AM

MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc (“Shire”).
//-->